Ozempic® and rash

Three different skin reactions

Ozempic® documents separate local reactions at the needle site from allergic (hypersensitivity) reactions that can involve the whole body. Rash and hives belong mainly to the second group, but a rash at the site of injection belongs to the first.

Reading the numbers

Injection-site reactions were rare in every pool and lower than many people expect. In Canada the placebo group actually reported them more often (0.8%) than the Ozempic® group (0.2%), which suggests that the needle and injection itself, not semaglutide, explain many of these ^[3]. The EU summary describes the reactions it counted as usually mild ^[2].

For allergic reactions, the EU uses a grouped term: “hypersensitivity” in its table covers events such as rash and urticaria and sits in the uncommon band, between 1 in 1,000 and 1 in 100 people ^[2]. The US label does not give a trial rate for rash or hives; they appear in the list of reactions reported voluntarily after approval, where frequency and cause cannot be established ^[1].

The EU summary also notes that 1% to 3% of patients developed antibodies to semaglutide at some point, but none had antibodies that neutralised it ^[2]. The documents do not link these antibodies to skin reactions.

What the research adds

A 2026 meta-analysis combined 14 randomised trials of GLP-1 medicines that reported injection-site reactions, covering 4,861 patients and 396 reactions ^[4]. Injection-site reactions were about three and a half times as likely with GLP-1 medicines as with comparators (risk ratio 3.55). Wider skin reactions were infrequent and not significantly raised. In the authors’ analysis of US FDA adverse-event reports, the strongest injection-site signals involved exenatide and dulaglutide rather than semaglutide ^[4].

The meta-analysis pooled several GLP-1 medicines, so it does not give a semaglutide-only figure, and reporting databases cannot show cause. Its message matches the labels: local reactions are the common skin effect, and body-wide rash is unusual.

Why a rash may appear

What the label supports: semaglutide can cause hypersensitivity reactions, including serious ones such as anaphylaxis and angioedema, and the US label says not to use Ozempic® in anyone who has had a previous allergic reaction to it ^[1]. Ozempic® also contains other ingredients, disodium phosphate dihydrate, propylene glycol, phenol and water, and the Medication Guide says not to use it if you have had a serious allergic reaction to semaglutide or any of them ^[1].

Proposed but unmeasured: a local reaction can come from the needle, the injection technique or skin irritation, which fits the higher placebo rate in Canada ^[3]. No Ozempic® study separates these causes.

If you have had anaphylaxis or angioedema with another GLP-1 medicine, the US label advises caution, because it is not known whether you are predisposed to the same reaction with Ozempic® ^[1].

Rashes with other causes

MedlinePlus lists many common causes of rash that are worth considering before blaming a medicine ^[5]:

• Contact dermatitis from soaps, detergents, cosmetics, latex or dyes in clothing.
• Eczema, psoriasis and seborrhoeic dermatitis.
• Infections such as impetigo or shingles, and viral illnesses.
• Insect bites or stings, and other medicines.
• Conditions such as lupus or rheumatoid arthritis; hives can also follow infections or stress ^[6].

What MedlinePlus suggests for mild rashes

For a simple rash, MedlinePlus suggests gentle skin care: avoid scrubbing, use mild cleansers and warm rather than hot water, pat dry, stop any newly added lotions or cosmetics and leave the area uncovered when you can ^[5]. It notes that an over-the-counter hydrocortisone cream may soothe many rashes; ask your pharmacist whether it suits you.

Hives often go away on their own, according to MedlinePlus, but swelling that affects the airway is an emergency ^[6]. MedlinePlus also stresses not changing or stopping a medicine without contacting your provider, unless you have signs of a serious allergic reaction, which the Ozempic® Medication Guide treats as a reason to stop and get help immediately ^[1][5].

Ozempic® details that help sort it out

Ozempic® goes into the belly, thigh or upper arm, and the label asks you to move to a new spot each week if you keep to one region ^[1]. If redness appears only where you injected, that location and the date are the most useful details. If a rash appears elsewhere, note when it started relative to your last injection, whether you have started any other medicine, soap or food, and whether it itches. MedlinePlus lists questions like these among those a clinician may ask ^[5].

Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help